Humankind Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,067
Closed -$2.19M 115
2025
Q3
$2.19M Sell
26,067
-1,604
-6% -$132K 0.5% 28
2025
Q2
$2.19M Sell
27,671
-4,233
-13% -$336K 0.53% 28
2025
Q1
$2.86M Buy
31,904
+2,995
+10% +$280K 0.74% 21
2024
Q4
$2.88M Buy
28,909
+5,248
+22% +$541K 0.73% 21
2024
Q3
$2.69M Buy
23,661
+4,348
+23% +$517K 0.97% 16
2024
Q2
$2.39M Sell
19,313
-1,296
-6% -$167K 0.63% 23
2024
Q1
$2.72M Sell
20,609
-3,322
-14% -$409K 0.72% 26
2023
Q4
$2.61M Buy
23,931
+1,476
+7% +$153K 0.77% 21
2023
Q3
$2.31M Buy
22,455
+1,149
+5% +$124K 0.96% 15
2023
Q2
$2.46M Buy
21,306
+3,792
+22% +$431K 0.96% 16
2023
Q1
$1.86M Sell
17,514
-678
-4% -$73.2K 0.77% 21
2022
Q4
$2.02M Sell
18,192
-2,349
-11% -$240K 0.88% 18
2022
Q3
$1.77M Buy
20,541
+3,647
+22% +$326K 0.85% 21
2022
Q2
$1.54M Sell
16,894
-1,161
-6% -$103K 0.74% 22
2022
Q1
$1.48M Buy
18,055
+1,725
+11% +$136K 0.61% 25
2021
Q4
$1.25M Buy
16,330
+1,233
+8% +$98.2K 1.58% 15
2021
Q3
$1.13M Sell
15,097
-539
-3% -$41K 1.73% 14
2021
Q2
$1.22M Buy
15,636
+5,460
+54% +$406K 2.16% 10
2021
Q1
$749K Buy
+10,176
New +$751K 2.3% 13

Other funds holding MRK

Humankind Investments's MRK Position: Q4 2025 in Review

Humankind Investments sold out of Merck (MRK) in Q4 2025, closing a stake of 26,067 shares — an estimated $2.19M sold.

Humankind Investments first reported a position in MRK in Q1 2021 and held it in 19 quarters. The position peaked at $2.88M in Q4 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Humankind Investments reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 26,067 Merck shares in Q4 2025, an estimated $2.19M.
  • Humankind Investments first reported a position in Merck in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Merck position peaked at $2.88M in Q4 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.